 |
 |
 |
|
Effectiveness and tolerability of Triumeq(DTG/ABC/3TC) in routine clinical care in Germany: First interim analysis of the TRIUMPH cohort
|
|
|
Reported by Jules Levin
16th European AIDS Conference, October 25-27, 2017. Milan
Cordes C1, Postel N2, Brust J3, GlaunsingerT4, Hillenbrand H5, Lutz T6, Moll A7, Scholten S8, Stoehr A9, WestermayerB10, Lüftenegger D11, Walli RK11
1Praxis Dr. Cordes, Berlin; 2prinzmed, Munich; 3Mannheimer OnkologiePraxis, Mannheim; 4Praxis PrenzlauerBerg, Berlin; 5Praxis City Ost, Berlin; 6Infektiologikum, Frankfurt; 7Praxiszentrum Kaiserdamm, Berlin; 8Praxis Hohenstaufenring, Cologne; 9IFI, Hamburg; 10GlaxoSmithKline, Munich; 11ViiV Healthcare, Munich




|
|
|
 |
 |
|
|